Maravai Lifesciences Holdings (MRVI) Other financing activities (2020 - 2026)

Maravai Lifesciences Holdings' Other financing activities history runs 7 years deep, the most recent figure standing at -$3.9 million for Q1 2026.

• On a quarterly basis, Other financing activities fell 9.21% year-over-year to -$3.9 million in Q1 2026; TTM through Mar 2026 was $1.0 million, a 68.86% decrease from a year earlier, with the FY2025 full-year figure at $1.4 million, down 85.19% from the prior year.
• Other financing activities eased to -$3.9 million in Q1 2026 per MRVI's latest filing, from $4.9 million in the prior quarter.
• Across five years, Other financing activities topped out at $4.9 million in Q2 2025 and bottomed at -$4.2 million in Q4 2023.
• The 5-year median for Other financing activities is $1.3 million (2022), against an average of $460285.7.
• Across the five-year window, Other financing activities soared 383.33% in 2024 and slumped 248.86% in 2025, its largest moves.
• Year by year, Other financing activities stood at -$2.0 million in 2022, then tumbled by 110.59% to -$4.2 million in 2023, then jumped by 153.01% to $2.2 million in 2024, then jumped by 120.9% to $4.9 million in 2025, then slumped by 178.66% to -$3.9 million in 2026.
• Per Business Quant, the three latest MRVI Other financing activities figures stand at -$3.9 million (Q1 2026), $4.9 million (Q2 2025), and -$3.5 million (Q1 2025).